Author: Bahareh Khalili, PhD, Manager, Solid-State Research & Development (SSRD) at Eurofins CDMO Alphora Inc.
Solid form screening, the activity of discovering and characterizing different solid forms of an active pharmaceutical ingredient (API), is an essential part of drug development. This screening process needs to be designed, performed and evaluated carefully, since the decisions made based on the screening may have consequences on the whole lifecycle of a pharmaceutical product. This paper discusses some basic principles about solid form screening and how we implement them at Eurofins CDMO Alphora to help our clients with this important task.
